Search for: "LANGE v. USA" Results 41 - 60 of 87
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Oct 2021, 7:15 am by Rechtsanwalt Martin Steiger
Wie lange speichert ProtonMail die IP-Adressen der Nutzerinnen und Nutzer? [read post]
17 Dec 2013, 4:15 am by Scott A. McKeown
As was made very recently apparent in Fresenius USA v. [read post]
21 Sep 2021, 4:00 am by Michael Woods and Gordon LaFortune
The United States has taken the next step in its trade dispute with Canada and asked for the establishment of a panel to examine its complaint regarding Canada’s administration of its tariff-rate quotas (TRQ) allocations for 14 dairy products.[1] In its request, the United States Trade Representative (USTR) [2] claims that Canada’s allocation of import quotas exclusively to “producers” violates the terms of Canada’s commitments in the schedule to annex 2-B[3] of the… [read post]
3 Dec 2013, 4:15 am by Scott A. McKeown
Yet, as made clear last week, the heightened standard necessary to institute an Inter Partes Review at the USPTO’s Patent Trial & Appeal Board (PTAB), coupled with the recent outcome in Fresenius USA v. [read post]
2 Dec 2010, 9:16 am by Roshonda Scipio
Volume I, Dynamic jurisprudential thought / Charles Mwalimu.Mwalimu, Charles.New York : Peter Lang, c2010.AntitrustKF1649.A2 C49 2009Circuit conflicts in antitrust litigation / John H. [read post]
20 Nov 2012, 10:25 am by Antonin I. Pribetic
The reasons why other jurisdictions have adopted approaches that differ from the approach adopted in the USA have been considered in a number of judgments, including, for example: the High Court of Australia in Lange v Australian Broadcasting Corporation [1997] HCA 25; (1997) 189 CLR 520, the Supreme Court of Canada in Hill v. [read post]
31 Aug 2014, 11:30 pm by Martin Steiger
Dem Verfahren Mannings war zudem eine lange Untersuchungshaft unter extremen Bedingungen vorangegangen. [read post]
On 4 December 2020, the English Patents Court handed down its decision in Neurim Pharmaceuticals (1991) Limited & Flynn Pharma Limited v Generics UK Limited (t/a Mylan) & Mylan UK Healthcare Limited, the main action proceedings regarding Neurim’s patent for Circadin, EP 1 441 702 (“EP 702”). [read post]
24 Aug 2020, 4:20 am by Florence Campbell Jones
In her judgment, handed down in April 2020, Mrs Justice Lang found that the NCA’s assumptions relating to the requirements which must be met in order to obtain a UWO were “unreliable”. [read post]